Search hospitals > British Columbia > VANCOUVER
University of British Columbia
Claim this profileVANCOUVER, British Columbia V6T 1Z4
Global Leader in Alzheimer's Disease
Global Leader in Depression
Conducts research for Multiple Sclerosis
Conducts research for Major Depressive Disorder
Conducts research for Stroke
213 reported clinical trials
18 medical researchers
Summary
University of British Columbia is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Alzheimer's Disease, Depression, Multiple Sclerosis, Major Depressive Disorder, Stroke and other specialties. University of British Columbia is involved with conducting 213 clinical trials across 328 conditions. There are 18 research doctors associated with this hospital, such as Fidel Vila-Rodriguez, MD, PhD, Robin Hsiung, MD, Andrei Krassioukov, MD,PhD,FRCPC, and Raymond W Lam, MD.Area of expertise
1Alzheimer's Disease
Global LeaderPSEN2 positive
PSEN1 positive
APP positive
2Depression
Global LeaderTop PIs
Fidel Vila-Rodriguez, MD, PhDNon-Invasive Neurostimulation Therapies (NINET) Laboratory, UBC Department of Psychiatry5 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
8 reported clinical trials
13 drugs studied
Robin Hsiung, MDUBC Hospital6 years of reported clinical research
Studies Alzheimer's Disease
Studies Dementia
8 reported clinical trials
13 drugs studied
Andrei Krassioukov, MD,PhD,FRCPCBlusson Spinal Cord Centre1 year of reported clinical research
Studies Spinal Cord Injury
Studies Neurogenic Bladder
5 reported clinical trials
9 drugs studied
Raymond W Lam, MDUniversity of British Columbia4 years of reported clinical research
Studies Depression
Studies Major Depressive Disorder
4 reported clinical trials
4 drugs studied
Clinical Trials running at University of British Columbia
Depression
Stroke
Alzheimer's Disease
Major Depressive Disorder
Ischemic Stroke
Opioid Use Disorder
Human Papillomavirus
Hemorrhagic Stroke
Cardiovascular Disease
Obstructive Sleep Apnea
Escitalopram + Brexpiprazole
for Depression
This study is evaluating whether a biomarker algorithm can predict treatment outcome for patients with a major depressive episode.
Recruiting3 awards Phase 48 criteria
Aticaprant
for Depression
The purpose of this study is to assess the long-term safety and tolerability of aticaprant administered as adjunctive therapy to a current antidepressant (selective serotonin reuptake inhibitor [SSRI] or serotonin and norepinephrine reuptake inhibitor [SNRI]) in all participants with major depressive disorder (MDD).
Recruiting2 awards Phase 316 criteria
Aticaprant
for Depression
The purpose of this study is to evaluate the efficacy of aticaprant compared with placebo as adjunctive therapy to an antidepressant in improving depressive symptoms in adult participants with major depressive disorder (MDD) with moderate to severe anhedonia (ANH+) who have had an inadequate response to current antidepressant therapy with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI).
Recruiting1 award Phase 39 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of British Columbia?
University of British Columbia is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Alzheimer's Disease, Depression, Multiple Sclerosis, Major Depressive Disorder, Stroke and other specialties. University of British Columbia is involved with conducting 213 clinical trials across 328 conditions. There are 18 research doctors associated with this hospital, such as Fidel Vila-Rodriguez, MD, PhD, Robin Hsiung, MD, Andrei Krassioukov, MD,PhD,FRCPC, and Raymond W Lam, MD.